At-home rapid antigen tests for COVID-19 offer a convenient method for detecting active infections. These tests typically involve a nasal swab sample applied to a test card. The card contains reagents that react with specific viral proteins, producing a visual result within minutes, indicating a positive or negative outcome. Digital readers, often paired with mobile applications, can be used with some tests to enhance result interpretation and facilitate reporting.
Rapid antigen tests, conducted outside of traditional laboratory settings, empower individuals to take proactive steps in managing their health and potentially limiting viral spread. The accessibility and speed of these tests play a crucial role in containing outbreaks, especially in situations where timely diagnosis is essential. The development and widespread availability of these tools represent a significant advancement in pandemic management, enabling broader access to testing and faster identification of active infections.
